Economic evaluation of the use of a pharmacogenetic diagnostic test in schizophrenia-Reference-Cited by-同舟云学术

Economic evaluation of the use of a pharmacogenetic diagnostic test in schizophrenia

Published:2014-12 Issue:4 Volume:3 Page:314-324
ISSN:2211-8837
Container-title:Health Policy and Technology
language:en
Short-container-title:Health Policy and Technology

Author:

Rejon-Parrilla Juan Carlos,Nuijten Mark,Redekop William K.,Gaultney Jennifer G.

Funder

Spanish Association of Health Economics

Publisher

Elsevier BV

Subject

Health Policy,Biomedical Engineering

Reference50 articles.

1. CYP2D6 genotyping for psychiatric patients treated with risperidone: considerations for cost-effectiveness studies;Rodriguez-Antona;Pharmacogenomics,2009

2. Economic and cost-effectiveness considerations for pharmacogenetics tests: an integral part of translational research and innovation uptake in personalized medicine;Paci;Curr Pharmacogenomics Pers Medicinenomics,2009

3. Challenges in the codevelopment of companion diagnostics;Moore;Pers Med,2012

4. Global burden of disease in young people aged 10–24 years: a systematic analysis;Gore;Lancet,2011

5. World Health Organization. International classification of diseases chapter V (F): mental and behavioural disorders (including disorders of psychological development). World Health Organization; 1990.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of pharmacogenetic testing to guide antipsychotic treatment;Nature Mental Health;2024-04-17

2. Acknowledging Patient Heterogeneity in Economic Evaluations in Schizophrenia: A Systematic Review;Value in Health;2022-01

3. Economic evaluation in psychiatric pharmacogenomics: a systematic review;The Pharmacogenomics Journal;2021-07-02

4. A Systematic Review of Economic Models Across the Entire Schizophrenia Pathway;PharmacoEconomics;2020-03-06

5. Potential therapeutic and economic value of risk-stratified treatment as initial treatment of multiple myeloma in Europe;Pharmacogenomics;2018-02